Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Egetis Therapeutics Major Shareholding Notification 2020

Nov 11, 2020

3152_iss_2020-11-11_d5a8fb1c-3b6a-4330-b99f-bae0a8e427b2.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Egetis Therapeutics AB (publ)

Holder

Cidro Förvaltning AB

Instrument

Instrument Aktie
Before the transaction
Shares 6,767,379
Voting rights 6,767,379
Transaction
Reason for major shareholding notification Sell
Date 10/11/2020
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 5,367,379
Directly held voting rights 5,367,379
Indirectly held voting rights 5,367,379
Percentage
Directly held shares 4.6 %
Directly held voting rights 4.6 %
Indirectly held voting rights 4.6 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 9.2 % 5,367,379
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 9.2 % 5,367,379
Published
11/11/2020 13:16
Contact
Name
Peter Lindell
Phone
0708496659 Email [email protected]

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25